These findings are in line with the proposed mechanism of AML1-ETO-mediated myeloid leukemias in which the AML1-ETO fusion disrupts PU.1-c-Jun interaction and thereby leads to a differentiation block and malignant transformation46. The gene discussed is RUNX1T1; the disease is myeloid leukemia.